H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.5% of adults in Frisco have diagnosed diabetes — 3.5 points below the U.S. 12% figure. Census population 219,587. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Frisco clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Frisco storefront.
Growth Factor Therapy for Tissue Repair in Frisco, TX for clinics & physicians. Growth factor therapy prod… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 8.5% of adults in Frisco have diagnosed diabetes — 3.5 points below the U.S. 12% figure. Census city-proper population is 219,587. If you are adding growth factor therapy, start with that epidemiology and with Novitas Solutions (JH) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)CDC PLACES (2023, crude) estimates 8.5% of adults in Frisco have diagnosed diabetes — 3.5 points below the U.S. 12% figure. Adult obesity in Frisco is 30% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 17.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, OK. Texas DSHS is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Frisco warehouse or a five-star local review. What you get is growth factor therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JH, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 8.5% of adults — 3.5 points below the U.S. 12% figure. Obesity is 30%; arthritis is 17.9%. That is place-level BRFSS modeling, not a clinic census and not a Frisco trial.
No. Novitas Solutions writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Novitas Solutions CTP articles. Mixing those codes is a billing error.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a Texas audit trail stays clean.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Frisco tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Frisco, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Frisco is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Frisco — 3.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Frisco. Useful for joint-program math; still needs a diagnosis and privileging.
No Frisco storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.